These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 39101735)

  • 21. Quality of reports on randomized controlled trials published in Iranian journals: application of the new version of consolidated standards of reporting trials (CONSORT).
    Nojomi M; Ramezani M; Ghafari-Anvar A
    Arch Iran Med; 2013 Jan; 16(1):20-2. PubMed ID: 23273230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria.
    Carmichael K; Nolan SJ; Weston J; Tudur Smith C; Marson AG
    Epilepsy Res; 2015 Aug; 114():106-13. PubMed ID: 26088893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.
    Montgomery P; Grant S; Mayo-Wilson E; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):407. PubMed ID: 30060754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Has the quality of abstracts for randomised controlled trials improved since the release of Consolidated Standards of Reporting Trial guideline for abstract reporting? A survey of four high-profile anaesthesia journals.
    Can OS; Yilmaz AA; Hasdogan M; Alkaya F; Turhan SC; Can MF; Alanoglu Z
    Eur J Anaesthesiol; 2011 Jul; 28(7):485-92. PubMed ID: 21037480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reporting quality of randomized controlled trial abstracts in the seven highest-ranking anesthesiology journals.
    Janackovic K; Puljak L
    Trials; 2018 Oct; 19(1):591. PubMed ID: 30373644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review.
    Hadi MA; McHugh GA; Conaghan PG
    Evid Based Med; 2017 Oct; 22(5):170-177. PubMed ID: 28866634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CONSORT Statement: Application within and adaptations for orthodontic trials.
    Pandis N; Fleming PS; Hopewell S; Altman DG
    Am J Orthod Dentofacial Orthop; 2015 Jun; 147(6):663-79. PubMed ID: 26038070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of reporting and fragility index for randomized controlled trials in the vesicoureteral reflux literature: where do we stand?
    Gnech M; Lovatt CA; McGrath M; Rickard M; Sanger S; Lorenzo AJ; Braga LH
    J Pediatr Urol; 2019 May; 15(3):204-212. PubMed ID: 31060965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of reports on randomized controlled trials conducted in Japan: evaluation of adherence to the CONSORT statement.
    Uetani K; Nakayama T; Ikai H; Yonemoto N; Moher D
    Intern Med; 2009; 48(5):307-13. PubMed ID: 19252352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using the CONSORT statement to evaluate the completeness of reporting of addiction randomised trials: a cross-sectional review.
    Vassar M; Jellison S; Wendelbo H; Wayant C; Gray H; Bibens M
    BMJ Open; 2019 Sep; 9(9):e032024. PubMed ID: 31494625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reporting quality of parallel randomised controlled trials in ophthalmic surgery in 2011: a systematic review.
    Yao AC; Khajuria A; Camm CF; Edison E; Agha R
    Eye (Lond); 2014 Nov; 28(11):1341-9. PubMed ID: 25214001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Have CONSORT guidelines improved the quality of reporting of randomised controlled trials published in public health dentistry journals?
    Savithra P; Nagesh LS
    Oral Health Prev Dent; 2013; 11(2):95-103. PubMed ID: 23534035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of reporting quality of randomized controlled trials investigating the effects of inulin-type fructans supplementation on cardiovascular disease risk factors: A systematic survey.
    Talukdar JR; Chu A; Garg A; Chowdhury F; E Harnack H; Huang L; Sikorski C; Mbuagbaw L; de Souza RJ
    PLoS One; 2024; 19(1):e0292184. PubMed ID: 38166017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence of trials of operative intervention to the CONSORT statement extension for non-pharmacological treatments: a comparative before and after study.
    Gray R; Sullivan M; Altman DG; Gordon-Weeks AN
    Ann R Coll Surg Engl; 2012 Sep; 94(6):388-94. PubMed ID: 22943327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reporting quality of heart failure randomized controlled trials 2000-2020: Temporal trends in adherence to CONSORT criteria.
    Jalloh MB; Bot VA; Borjaille CZ; Thabane L; Li G; Butler J; Zannad F; Granger CB; Van Spall HGC
    Eur J Heart Fail; 2024 Jun; 26(6):1369-1380. PubMed ID: 38623814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting of critical care trial abstracts: a comparison before and after the announcement of CONSORT guideline for abstracts.
    Kuriyama A; Takahashi N; Nakayama T
    Trials; 2017 Jan; 18(1):32. PubMed ID: 28109324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot and feasibility trials in surgery are incompletely reported according to the CONSORT checklist: a meta-research study.
    McKechnie T; Kazi T; Wang A; Zhang S; Thabane A; Nanji K; Staibano P; Park LJ; Doumouras A; Eskicioglu C; Thabane L; Parpia S; Bhandari M
    J Clin Epidemiol; 2024 Jun; 170():111335. PubMed ID: 38548230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension.
    Hodkinson A; Kirkham JJ; Tudur-Smith C; Gamble C
    BMJ Open; 2013 Sep; 3(9):e003436. PubMed ID: 24078752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist.
    Devereaux PJ; Manns BJ; Ghali WA; Quan H; Guyatt GH
    Control Clin Trials; 2002 Aug; 23(4):380-8. PubMed ID: 12161081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the reporting quality of randomised controlled trials for vitamin D supplementation in autoimmune thyroid disorders based on the CONSORT statement.
    Vrysis C; Beneki E; Zintzaras E; Doxani C
    Endocrine; 2023 May; 80(2):346-354. PubMed ID: 36462148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.